Argentina Menopause Drugs Market - Industry Trends and Forecast to 2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	136 Pages	Data Bridge Market Research	January, 2022	DAABD17232271

Best Price Guarantee
Price	from $3,500
Length	136 Pages
Publisher	Data Bridge Market Research
Published Date	January, 2022
SKU	DAABD17232271

Argentina Menopause Drugs Market - Industry Trends and Forecast to 2029

Argentina menopause drugs market is projected to register a substantial CAGR of 4.6% in the forecast period of 2022 to 2029 The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029

Market Segmentation:

Argentina Menopause Drugs Market, By Stages (Postmenopause, Perimenopause and Menopause), Type (Non-Hormonal Therapy and Hormonal Therapy), Menopause Symptoms (Vasomotor Symptoms, Atrophic Vaginitis, Dyspareunia, Osteoporosis, Joint Pain, Depression, Weight Gain and Others), Dosage Form (Tablet, Cream, Patch/Film, Rings, Gel, Injection Shot, Spray and Others), Route of Administration (Oral, Parenteral, Transdermal, Vaginal and Others), End User (Hospitals, Clinic Home Healthcare and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), Country (Argentina) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the Argentina menopause drugs market are:
• The rise in collaboration, with the research and development (R&D) of the pharmaceutical companies for the production of menopause drugs
• The rise in product approvals of dietary supplements

Market Players:

The key market players for Argentina menopause drugs market are listed below:
• Laboratorios Bagó S.A.
• Química Montpellier SA.
• GADOR S.A.
• Laboratorio Elea Phoenix S.A.
• ROEMMERS SAICF
• ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A.
• Abbott. Laboratorios Bernabó
• GlaxoSmithKline plc
• TEMIS LOSTALO
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Allergan
• Teva Pharmaceutical Industries Ltd.
• Bayer AG

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Argentina Menopause Drugsmarket; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Argentina Menopause Drugsmarket: Segmentation: 2.1 Markets Covered; 2.2 Country Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Cause Segment Lifeline Curve; 2.8 Dbmr Market Position Grid; 2.9 Vendor Share Analysis; 2.10 Market End User Coverage Grid; 2.11 Secondary Sources
3 Executive Summary
4 Premium Insights: 4.1 Porters Five Forces; 4.2 Pestel Analysis
5 Epidemiology
6 Argentina Menopause Drugs Market: Regulations: 6.1 Argentina; 6.2 Country Specific Requirements
7 Pipeline Analysis, Argentina Menopause Drugs Market
8 Summary Write Up (Argentina): 8.1 Overview
9 Market Overview: 9.1 Drivers; 9.1.1 Rise In Research And Development; 9.1.2 Rise In Ageing Population Among Women In Argentina; 9.1.3 Rise In Product Approval; 9.1.4 Rise In Government Initiatives And Organizations; 9.1.5 Reimbursement For Menopause Treatment; 9.2 Restraints; 9.2.1 Rise In Cost Of Menopause Drugs And Hormonal Therapy; 9.2.2 Complexity In Menopause; 9.2.3 Rise In Product Recall; 9.2.4 Lack Of Awareness About Menopause; 9.3 Opportunities; 9.3.1 Strategic Initiative By Market Players; 9.3.2 Rise In Healthcare Expenditure; 9.3.3 Use Of Dietary Supplements; 9.4 Challenges; 9.4.1 Side Effects Caused Due To Drugs Taken For Menopause Treatment; 9.4.2 Stringent Regulations
10 Impact Of Covid-19 On Argentina Menopause Drugs Market: 10.1 Impact On Price; 10.2 Impact On Demand; 10.3 Impact On Supply Chain; 10.4 Strategic Decisions By Manufacturers; 10.5 Conclusion
11 Argentina Menopause Drugs Market, By Stages: 11.1 Overview; 11.2 Postmenopause; 11.3 Perimenopause; 11.4 Menopause
12 Argentina Menopause Drugs Market, By Type: 12.1 Overview; 12.2 Non-hormonal Therapy; 12.2.1 Medication; 12.2.1.1 Paroxetine; 12.2.1.2 Anti-depressants; 12.2.1.3 Gabapentin; 12.2.1.4 Clonidine; 12.2.1.5 Ospemifene; 12.2.1.6 Others; 12.2.2 Supplements; 12.2.2.1 Herbal Supplements; 12.2.2.1.1 Ginseng; 12.2.2.1.2 Ashwagandha; 12.2.2.1.3 Others; 12.2.2.2 Vitamin D; 12.2.2.3 Others; 12.3 Hormonal Therapy; 12.3.1 Estrogen; 12.3.1.1 17 B- Estradiol; 12.3.1.2 Conjugated Estrogen; 12.3.1.3 Estradiol Hemihydrate; 12.3.1.4 Esterified Estrogen; 12.3.1.5 Esterified Acetate; 12.3.1.6 Estropipate; 12.3.1.7 Others; 12.3.2 Combined Estrogen & Progestogen Drugs; 12.3.2.1 17 B- Estradiol (E) + Norethinodrone Acetate (P); 12.3.2.2 Conjugated Estrogens (E) + Medroxyprogesterone Acetate (P); 12.3.2.3 Ethinyl Estradiol (E) + Norethindrone Acetate (P); 12.3.2.4 Others; 12.3.3 Medroxyprogesterone Acetate
13 Argentina Menopause Drugs Market, By Menopause Symptoms: 13.1 Overview; 13.2 Vasomotor Symptoms; 13.2.1 Hormonal Therapy; 13.2.2 Non- Hormonal Therapy; 13.3 Atrophic Vaginitis; 13.3.1 Hormonal Therapy; 13.3.2 Non- Hormonal Therapy; 13.4 Dyspareunia; 13.4.1 Non- Hormonal Therapy; 13.4.2 Hormonal Therapy; 13.5 Osteoporosis; 13.5.1 Non- Hormonal Therapy; 13.5.2 Hormonal Therapy; 13.6 Joint Pain; 13.6.1 Non- Hormonal Therapy; 13.6.2 Hormonal Therapy; 13.7 Depression; 13.7.1 Non- Hormonal Therapy; 13.7.2 Hormonal Therapy; 13.8 Weight Gain; 13.8.1 Hormonal Therapy; 13.8.2 Non- Hormonal Therapy; 13.9 Others
14 Argentina Menopause Drugs Market, By Dosage Form: 14.1 Overview; 14.2 Tablet; 14.3 Cream; 14.4 Patch/Film; 14.5 Rings; 14.6 Gel; 14.7 Injection Shot; 14.8 Spray; 14.9 Others
15 Argentina Menopause Drugs Market, By Route Of Administration: 15.1 Overview; 15.2 Oral; 15.3 Parenteral; 15.3.1 Intravenous; 15.3.2 Subcutaneous; 15.3.3 Others; 15.4 Transdermal; 15.5 Vaginal; 15.6 Others
16 Argentina Menopause Drugs Market, By End User: 16.1 Overview; 16.2 Hospital; 16.3 Clinics; 16.4 Home Healthcare; 16.5 Others
17 Argentina Menopause Drugs Market, By Distribution Channel: 17.1 Overview; 17.2 Retail Pharmacy; 17.3 Hospital Pharmacy; 17.4 Online Pharmacy
18 Argentina Menopause Drugs Market: Company Landscape: 18.1 Company Share Analysis: Argentina
19 Swot Analysis
20 Company Profile: 20.1 Pfizer Inc.; 20.1.1 Company Snapshot; 20.1.2 Revenue Analysis; 20.1.3 Product Portfolio; 20.1.4 Recent Developments; 20.2 Bayer Ag; 20.2.1 Company Snapshot; 20.2.2 Revenue Analysis; 20.2.3 Product Portfolio; 20.2.4 Recent Developments; 20.3 Novartis Ag; 20.3.1 Company Snapshot; 20.3.2 Revenue Analysis; 20.3.3 Product Portfolio; 20.3.4 Recent Developments; 20.4 Laboratorios Bago S.A.; 20.4.1 Company Snapshot; 20.4.2 Product Portfolio; 20.4.3 Recent Developments; 20.5 Glaxosmithkline Plc(2021); 20.5.1 Company Snapshot; 20.5.2 Revenue Analysis; 20.5.3 Product Portfolio; 20.5.4 Recent Development; 20.6 Teva Pharmaceutical Industries Ltd.; 20.6.1 Company Snapshot; 20.6.2 Revenue Analysis; 20.6.3 Product Portfolio; 20.6.4 Recent Developments; 20.6.4.1 Partnership; 20.6.4.2 Product Launch; 20.7 Novo Nordisk A/S; 20.7.1 Company Snapshot; 20.7.2 Revenue Analysis; 20.7.3 Product Portfolio; 20.7.4 Recent Development; 20.8 Abbvie Inc.; 20.8.1 Company Snapshot; 20.8.2 Revenue Analysis; 20.8.3 Product Portfolio; 20.8.4 Recent Developments; 20.9 Abbott; 20.9.1 Company Snapshot; 20.9.2 Revenue Analysis; 20.9.3 Product Portfolio; 20.9.4 Recent Development; 20.10 Ache Laboratórios Farmacêuticos S/A; 20.10.1 Company Snapshot; 20.10.2 Revenue Analysis; 20.10.3 Product Portfolio; 20.10.4 Recent Developments; 20.11 Gador S.A.; 20.11.1 Company Snapshot; 20.11.2 Product Portfolio; 20.11.3 Recent Developments; 20.12 Laboratorios Bernabo S.A.; 20.12.1 Company Snapshot; 20.12.2 Product Portfolio; 20.12.3 Recent Developments; 20.13 Laboratorio Elea Phoenix S.A.; 20.13.1 Company Snapshot; 20.13.2 Product Portfolio; 20.13.3 Recent Development; 20.13.3.1 Product Launch; 20.14 Quimica Montpellier S.A.; 20.14.1 Company Snapshot; 20.14.2 Product Portfolio; 20.14.3 Recent Developments; 20.15 Roemmers Saicf; 20.15.1 Company Snapshot; 20.15.2 Product Portfolio; 20.15.3 Recent Developments; 20.16 Temis Loslato; 20.16.1 Company Snapshot; 20.16.2 Product Portfolio; 20.16.3 Recent Developments
21 Questionnaire
22 Related Reports
List Of Tables: Table 1 Argentina Menopause Drugs Market, By Stages, 2020-2029 (Usd Million); Table 2 Argentina Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 3 Argentina Non –hormonal Therapy In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 4 Argentina Medication In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 5 Argentina Supplements In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 6 Argentina Herbal Supplements In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 7 Argentina Hormonal Therapy In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 8 Argentina Estrogen In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 9 Argentina Combined Estrogen & Progestogen Drugs In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 10 Argentina Menopause Drugs Market, By Menopause Symptoms, 2020-2029 (Usd Million); Table 11 Argentina Vasomotor Symptoms In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 12 Argentina Atrophic Vaginitis In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 13 Argentina Dyspareunia In Menopause Drugs Market, By Type2020-2029 (Usd Million); Table 14 Argentina Osteoporosis In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 15 Argentina Joint Pain In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 16 Argentina Depression In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 17 Argentina Weight Gain In Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Table 18 Argentina Menopause Drugs Market, By Dosage Form, 2020-2029 (Usd Million); Table 19 Argentina Menopause Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 20 Argentina Parenteral In Menopause Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 21 Argentina Menopause Drugsmarket, By End User, 2020-2029 (Usd Million); Table 22 Argentina Menopause Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
List Of Figures: Figure 1 Argentina Menopause Drugsmarket: Segmentation; Figure 2 Argentina Menopause Drugsmarket: Data Triangulation; Figure 3 Argentina Menopause Drugsmarket: Droc Analysis; Figure 4 Argentina Menopause Drugsmarket: Regional Vs Country Analysis; Figure 5 Argentina Menopause Drugsmarket: Company Research Analysis; Figure 6 Argentina Menopause Drugsmarket: Interview Demographics; Figure 7 Argentina Menopause Drugs Market: Dbmr Position Grid; Figure 8 Argentina Menopause Drugsmarket: Vendor Share Analysis; Figure 9 Argentina Menopause Drugs Market: End User Coverage Grid; Figure 10 Argentina Menopause Drugs Market: Segmentation; Figure 11 Rise In Product Appprovals Is Expected To Drive The Argentina Menopause Drugs Market From 2022 To 2029; Figure 12 Postmenopause Segment Is Expected To Have The Largest Share Of The Argentina Menopause Drugs Market From 2022 & 2029; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of Argentina Menopause Drugs Market; Figure 14 Estimated Age Of Women, Aged Above 45 Years, Undergoing Menopause In 2020; Figure 15 Argentina Menopause Drugs Market, By Stages, 2021; Figure 16 Argentina Menopause Drugs Market, By Stages, 2020-2029 (Usd Million); Figure 17 Argentina Menopause Drugs Market, By Stages, Cagr (2022-2029); Figure 18 Argentina Menopause Drugs Market, By Stages, Lifeline Curve; Figure 19 Argentina Menopause Drugs Market, By Type, 2021; Figure 20 Argentina Menopause Drugs Market, By Type, 2020-2029 (Usd Million); Figure 21 Argentina Menopause Drugs Market, By Type, Cagr (2022-2029); Figure 22 Argentina Menopause Drugs Market, By Type, Lifeline Curve; Figure 23 Argentina Menopause Drugs Market, By Menopause Symptoms, 2021; Figure 24 Argentina Menopause Drugs Market, By Menopause Symptoms, 2020-2029 (Usd Million); Figure 25 Argentina Menopause Drugs Market, By Menopause Symptoms, Cagr (2022-2029); Figure 26 Argentina Menopause Drugs Market, By Menopause Symptoms, Lifeline Curve; Figure 27 Argentina Menopause Drugs Market, By Dosage Form, 2021; Figure 28 Argentina Menopause Drugs Market, By Dosage Form, 2020-2029 (Usd Million); Figure 29 Argentina Menopause Drugs Market, By Dosage Form, Cagr (2022-2029); Figure 30 Argentina Menopause Drugs Market, By Dosage Form, Lifeline Curve; Figure 31 Argentina Menopause Drugs Market, By Route Of Administration, 2021; Figure 32 Argentina Menopause Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Figure 33 Argentina Menopause Drugs Market, By Route Of Administration, Cagr (2022-2029); Figure 34 Argentina Menopause Drugs Market, By Route Of Administration, Lifeline Curve; Figure 35 Argentina Menopause Drugs Market, By End User, 2021; Figure 36 Argentina Menopause Drugs Market, By End User, 2020-2029 (Usd Million); Figure 37 Argentina Menopause Drugs Market, By End User, Cagr (2022-2029); Figure 38 Argentina Menopause Drugs Market, By End User, Lifeline Curve; Figure 39 Argentina Menopause Drugs Market, By Distribution Channel, 2021; Figure 40 Argentina Menopause Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Figure 41 Argentina Menopause Drugs Market, By Distribution Channel, Cagr (2022-2029); Figure 42 Argentina Menopause Drugs Market, By Distribution Channel, Lifeline Curve; Figure 43 Argentina Menopause Drugs Market: Company Share 2021 (%)